• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对……开发多表位组织蛋白酶L驱动的短肽疫苗。 (原文against后内容缺失)

Development of multi-epitope Cathepsin L driven short peptide vaccine against .

作者信息

Chansap Supanan, Cheukamud Werachon, Suthisintong Thitikul, Kueakhai Pornanan, Changklungmoa Narin

机构信息

Research Unit for Vaccine and Diagnosis of Parasitic Diseases, Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.

出版信息

Front Vet Sci. 2025 May 22;12:1547937. doi: 10.3389/fvets.2025.1547937. eCollection 2025.

DOI:10.3389/fvets.2025.1547937
PMID:40475029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12139528/
Abstract

Fasciolosis is an important zoonotic disease caused by species ( spp.). spp. infection has the potential to affect the livestock economy. Furthermore, liver flukes have been found to present Triclabendazole resistance in many countries. Vaccines are used to prevent fasciolosis and are currently considered the best alternative. However, no liver fluke vaccine is commercially available at present. Cathepsin Ls (FgCatLs) are vital enzymes for the liver fluke's survival. Therefore, this study aimed to design and investigate the immune response of multi-epitope Cathepsin L (MeCatL) driven short peptide vaccine for fasciolosis using immunoinformatic tools. FgCatLs sequences were predicted Linear B cell (BCL)- and Helper T lymphocyte (HTL)-specific immunogenic Eepitopes. The selected epitopes were marked on FgCatL's alignments. Novel epitopes were constructed from three criteria, including the selection process taking non-conserved host regions, overlapping FgCatLs sequences, and the highest percent conserved residues. Novel epitopes of BCL and HTL were linked with a linker to design a short peptide. MeCatL driven short peptide presented high antigenicity, non-allergenicity, non-toxicity, and good solubility. MeCatL driven short peptide was predicted and refined the tertiary structure. The refined MeCatL driven short peptide model indicated good quality structure that was investigated by Ramachandran plot, ERRAT, and Z-score. The refined MeCatL driven short peptide model interacted with Toll-like receptor 2 (TLR-2). The lowest energy was -1222.4 kJ/mol. The levels of IgM, IgG1, and IgG2 were increased in immune simulation. MeCatL driven short peptide was synthesized and immunized in mice. IgG1 and IgG2a levels were increased after week 2, indicating IgG1 levels were dominating. MeCatL driven short peptide immunized sera can detect single proteins, including rFgCatL1, rFgCatL1G, and rFgCatL1H. In addition, MeCatL driven short peptide immunized sera was specifically detected in the cecal epithelium of NEJ and adult stages. These findings suggest that the MeCatL short peptide is a promising vaccine candidate, capable of inducing targeted immune responses, though further studies are needed to confirm its protective efficacy .

摘要

肝片吸虫病是由肝片吸虫属(Fasciola spp.)引起的一种重要的人畜共患病。Fasciola spp.感染有可能影响畜牧业经济。此外,在许多国家已发现肝片吸虫对三氯苯达唑产生耐药性。疫苗用于预防肝片吸虫病,目前被认为是最佳选择。然而,目前尚无商业化的肝片吸虫疫苗。组织蛋白酶L(FgCatLs)是肝片吸虫生存的关键酶。因此,本研究旨在利用免疫信息学工具设计并研究多表位组织蛋白酶L(MeCatL)驱动的肝片吸虫病短肽疫苗的免疫反应。预测FgCatLs序列的线性B细胞(BCL)和辅助性T淋巴细胞(HTL)特异性免疫原性表位。在FgCatL的比对中标记所选表位。根据三个标准构建新表位,包括选择非保守的宿主区域、重叠FgCatLs序列以及最高百分比的保守残基。将BCL和HTL的新表位用连接子连接以设计短肽。MeCatL驱动的短肽具有高抗原性、无致敏性、无毒性且溶解性良好。预测并优化了MeCatL驱动短肽的三级结构。通过拉氏图、ERRAT和Z分数对优化后的MeCatL驱动短肽模型的质量结构进行了研究,结果表明其结构良好。优化后的MeCatL驱动短肽模型与Toll样受体2(TLR - 2)相互作用,最低能量为 - 1222.4 kJ/mol。在免疫模拟中,IgM、IgG1和IgG2水平升高。合成MeCatL驱动的短肽并在小鼠中进行免疫。第2周后IgG1和IgG2a水平升高,表明IgG1水平占主导。MeCatL驱动的短肽免疫血清可检测包括rFgCatL1、rFgCatL1G和rFgCatL1H在内的单一蛋白质。此外,在日本分体吸虫童虫和成虫阶段的盲肠上皮中特异性检测到MeCatL驱动的短肽免疫血清。这些发现表明,MeCatL短肽是一种有前景的疫苗候选物,能够诱导靶向免疫反应,不过还需要进一步研究来证实其保护效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/de5d655d49d0/fvets-12-1547937-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/f215aa1a27d2/fvets-12-1547937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/b69e709bfdbd/fvets-12-1547937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/97ff2f15684c/fvets-12-1547937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/49d55b83b412/fvets-12-1547937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/211a3619c841/fvets-12-1547937-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/b1da5919ed01/fvets-12-1547937-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/0b336cdae041/fvets-12-1547937-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/739135c58fc8/fvets-12-1547937-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/04ffb98d935b/fvets-12-1547937-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/ad4af0638179/fvets-12-1547937-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/0daad6d6f113/fvets-12-1547937-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/de5d655d49d0/fvets-12-1547937-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/f215aa1a27d2/fvets-12-1547937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/b69e709bfdbd/fvets-12-1547937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/97ff2f15684c/fvets-12-1547937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/49d55b83b412/fvets-12-1547937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/211a3619c841/fvets-12-1547937-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/b1da5919ed01/fvets-12-1547937-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/0b336cdae041/fvets-12-1547937-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/739135c58fc8/fvets-12-1547937-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/04ffb98d935b/fvets-12-1547937-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/ad4af0638179/fvets-12-1547937-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/0daad6d6f113/fvets-12-1547937-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e093/12139528/de5d655d49d0/fvets-12-1547937-g012.jpg

相似文献

1
Development of multi-epitope Cathepsin L driven short peptide vaccine against .针对……开发多表位组织蛋白酶L驱动的短肽疫苗。 (原文against后内容缺失)
Front Vet Sci. 2025 May 22;12:1547937. doi: 10.3389/fvets.2025.1547937. eCollection 2025.
2
Monoclonal antibody against recombinant Fasciola gigantica cathepsin L1H could detect juvenile and adult cathepsin Ls of Fasciola gigantica.针对重组大片吸虫组织蛋白酶L1H的单克隆抗体能够检测大片吸虫的幼虫和成虫组织蛋白酶L。
Parasitol Res. 2015 Jan;114(1):133-40. doi: 10.1007/s00436-014-4170-8. Epub 2014 Oct 17.
3
Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach.利用免疫信息学方法研制抗巨型片形吸虫的多表位亚单位疫苗。
Int J Biol Macromol. 2019 Oct 1;138:224-233. doi: 10.1016/j.ijbiomac.2019.07.024. Epub 2019 Jul 4.
4
Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.用重组幼虫特异性组织蛋白酶L对小鼠进行疫苗接种以预防巨大片吸虫感染
Vaccine. 2015 Mar 24;33(13):1596-601. doi: 10.1016/j.vaccine.2015.02.010. Epub 2015 Feb 17.
5
Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.重组组织蛋白酶L1前体和成熟体对小鼠大片吸虫病的疫苗潜力
Acta Trop. 2015 Oct;150:71-8. doi: 10.1016/j.actatropica.2015.06.020. Epub 2015 Jun 24.
6
Designing a vaccine for fascioliasis using immunogenic 24 kDa mu-class glutathione s-transferase.利用免疫原性 24kDa μ 类谷胱甘肽 s-转移酶设计片形吸虫病疫苗。
Infect Genet Evol. 2020 Sep;83:104352. doi: 10.1016/j.meegid.2020.104352. Epub 2020 May 7.
7
Fasciola gigantica vaccine construct: an in silico approach towards identification and design of a multi-epitope subunit vaccine using calcium binding EF-hand proteins.巨片形吸虫疫苗构建:一种使用钙结合 EF 手蛋白鉴定和设计多表位亚单位疫苗的计算机方法。
BMC Immunol. 2023 Jan 5;24(1):1. doi: 10.1186/s12865-022-00535-y.
8
Construction and mouse antibody response evaluation of juvenile stage-specific chimeric protein from Fasciola gigantica.日本血吸虫成虫阶段特异性重组蛋白的构建及其鼠抗体反应的评价。
Vet Parasitol. 2024 Oct;331:110254. doi: 10.1016/j.vetpar.2024.110254. Epub 2024 Jul 14.
9
Molecular cloning, characterization and functional analysis of a novel juvenile-specific cathepsin L of Fasciola gigantica.分子克隆、鉴定及功能分析华支睾吸虫新型幼期特异性组织蛋白酶 L。
Acta Trop. 2013 Oct;128(1):76-84. doi: 10.1016/j.actatropica.2013.06.013. Epub 2013 Jun 29.
10
Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.用一种新型多表位 ROP8 DNA 疫苗对急性弓形虫感染进行免疫接种可诱导小鼠产生强烈的 B 和 T 细胞应答。
Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101413. doi: 10.1016/j.cimid.2020.101413. Epub 2020 Jan 8.

引用本文的文献

1
Design of a Multi-Epitope Vaccine Based on Cathepsin B and Evaluation of Immunological Responses in Mice.基于组织蛋白酶B的多表位疫苗设计及小鼠免疫反应评估
Int J Mol Sci. 2025 Jul 20;26(14):6971. doi: 10.3390/ijms26146971.

本文引用的文献

1
Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins.利用来自免疫显性gp46和gp63蛋白的诱导IFN-γ表位设计抗利什曼病的多表位疫苗。
J Genet Eng Biotechnol. 2024 Mar;22(1):100355. doi: 10.1016/j.jgeb.2024.100355. Epub 2024 Feb 2.
2
Immunoinformatics-aided rational design of a multi-epitope vaccine targeting feline infectious peritonitis virus.免疫信息学辅助设计靶向猫传染性腹膜炎病毒的多表位疫苗的合理设计。
Front Vet Sci. 2023 Dec 13;10:1280273. doi: 10.3389/fvets.2023.1280273. eCollection 2023.
3
Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouth disease virus induced by vaccination.
肝片形吸虫感染改变了接种口蹄疫疫苗后针对口蹄疫病毒的 IgG1 特异性免疫应答。
Vaccine. 2024 Jan 25;42(3):541-547. doi: 10.1016/j.vaccine.2023.12.067. Epub 2024 Jan 6.
4
Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development.肝片吸虫病:发病机制、宿主-寄生虫相互作用及在疫苗研发中的意义
Front Vet Sci. 2023 Dec 11;10:1270064. doi: 10.3389/fvets.2023.1270064. eCollection 2023.
5
Antibody Cross-Reactivity in Auto-Immune Diseases.自身免疫性疾病中的抗体交叉反应性。
Int J Mol Sci. 2023 Sep 2;24(17):13609. doi: 10.3390/ijms241713609.
6
The global prevalence of human fascioliasis: a systematic review and meta-analysis.全球人体片形吸虫病的流行率:一项系统评价和荟萃分析。
Ther Adv Infect Dis. 2023 Jul 8;10:20499361231185413. doi: 10.1177/20499361231185413. eCollection 2023 Jan-Dec.
7
Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine.用于设计和开发基于多表位的肽疫苗的计算和生物信息学工具及数据库的进展
Int J Pept Res Ther. 2023;29(4):60. doi: 10.1007/s10989-023-10535-0. Epub 2023 May 23.
8
PEP-FOLD4: a pH-dependent force field for peptide structure prediction in aqueous solution.PEP-FOLD4:一种在水溶液中预测肽结构的 pH 依赖力场。
Nucleic Acids Res. 2023 Jul 5;51(W1):W432-W437. doi: 10.1093/nar/gkad376.
9
Cathepsin L1H: High Sensitivity and Specificity of Immunochromatographic Strip Test for Antibody Detection.组织蛋白酶L1H:免疫层析试纸条检测抗体的高灵敏度和特异性
Trop Med Infect Dis. 2023 Mar 11;8(3):164. doi: 10.3390/tropicalmed8030164.
10
Revisiting the Ramachandran plot based on statistical analysis of static and dynamic characteristics of protein structures.基于蛋白质结构静态和动态特征的统计分析重新审视拉马钱德兰图。
J Struct Biol. 2023 Mar;215(1):107939. doi: 10.1016/j.jsb.2023.107939. Epub 2023 Jan 24.